• North America
  • North America |
  • Europe
  |
• Demo Center |
• Success Center |
• Careers |
• Contact Us |
• Support

Veeva customers, such as Genentech, Millennium, and Indevus, are industry leaders and innovators. From the world's largest pharmaceutical companies to biotechs hiring their very first sales teams, Veeva Systems has already replaced every major packaged solution from our client/server competitors, proving that the SaaS model is far superior for today's marketplace. The future of Pharma CRM is here today.

	Accera, Inc. is a privately held commercial-stage biotechnology company that developed and now markets Axona in the US. Axona is a prescription-only medical food intended for the clinical dietary management of the metabolic processes associated with mild-to-moderate Alzheimer's disease. Accera is engaged in the research, development and commercialization of other clinical applications for Axona in acute and chronic neurodegenerative diseases. For more information about Accera, please visit www.accerapharma.com.
	Adamas is an emerging pharmaceutical company focused on developing small molecule, Advantaged TherapeuticsTM to treat neurological and infectious diseases, including influenza A, the cause of the current flu pandemic. Adamas’ approach to pharmaceutical development is to identify synergistic drug mechanisms that can be developed as optimized combination drug therapies to increase safety, efficacy and compliance, thus improving upon the standard of care. Adamas is headquartered in Emeryville, California, with operations in Bangalore, India. For more information about Adamas, please visit www.adamaspharma.com.
	Avidas Pharmaceuticals LLC is a privately-held company committed to age-related disorders and diseases. With a primary focus in the areas of dermatology, endocrinology and women's healthcare, Avidas is committed to serving the unique needs of healthcare providers and patients through product expertise, medical education and customer service.
	Genentech has been delivering on the promise of biotechnology for more than 30 years. Today, Genentech is among the world's leading biotech companies, with multiple products on the market for serious or life-threatening medical conditions, more than 100 projects in the pipeline and a long term plan for growth.
	Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) is a specialty pharmaceutical company focused on the acquisition, development and commercialization of innovative pharmaceutical products, primarily in the fields of urology and endocrinology. With a robust and diversified pipeline, Indevus is becoming an emerging leader in urology and endocrinology.
	JHP Pharmaceuticals, located in Parsippany, New Jersey, is an integrated specialty healthcare company that specializes in sterile injectable products. JHP manufactures and sells brand aseptic injectable pharmaceuticals in hospital and clinical settings and provides contract manufacturing services for global pharmaceutical companies. JHP's own product portfolio includes leading diagnostic, women's health and anesthesia products. All products have a long track record of "gold standard" service and are at or near the front line of treatment in their therapeutic indications.
	Millennium Pharmaceuticals, Inc., The Takeda Oncology Company, a leading biopharmaceuticalcompany based in Cambridge, Mass., markets VELCADE, a novel cancer product, and has a robust clinical development pipeline of product candidates. Millennium research, development and commercialization activities are focused in two therapeutic areas: oncology and inflammation. View the Veeva Case Study
	OSI Pharmaceuticals is committed to "shaping medicine and changing lives" by discovering, developing and commercializing high-quality, novel and differentiated targeted medicines designed to extend life and improve the quality of life for patients with cancer and diabetes/obesity.
	PDI provides commercialization services for established and emerging biopharmaceutical companies. The Company is dedicated to maximizing the return on investment for its clients by providing strategic flexibility, sales, marketing and commercialization expertise. For more information on PDI, click here to go to their website.
	ProStrakan is a rapidly growing specialty pharmaceutical company engaged in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. View the Veeva Case Study
	Publicis Managed Markets (PMM) offers the biopharmaceutical industry comprehensive managed markets solutions including strategy, tactics, and execution services across all managed markets channels. PMM provides emerging pharma and biotech companies with the expertise needed to impact managed markets channels for early product commercialization, as well as delivering coverage for under-represented brands in Big Pharma through end-stages of the product lifecycle.
	Publicis Selling Solutions provides sales teams and support services to pharmaceutical and biotech companies nationwide. Providing the industry's most experienced biopharma sales professionals, Publicis Selling Solutions offers a comprehensive range of sales teams, including specialty, biotech, hospital, primary care, customer service, and blended sales forces, as well as providing clinical health educators, managed markets account directors, and vacant territory management.
	QLT is dedicated to developing innovative ocular products. We intend to commercialize these products ourselves in North America and strive to deliver meaningful return to our shareholders as our current development products reach the market over the next 10 years. We will seek to become a top-tier ophthalmology company based on our development innovation, strong commercial presence, and focus on ocular drugs and devices.
	Quintiles is the only fully integrated bio and pharmaceutical services provider offering clinical, commercial, consulting and capital solutions. Our 23,000 employees in more than 50 countries have helped develop or commercialize all of the top 30 best-selling drugs.
	Solstice Neurosciences, Inc. is an emerging specialty biopharmaceutical company focused on the development, manufacturing, sales and marketing of specialty biopharmaceutical products. Solstice's first product, Myobloc®/Neurobloc®, represents the only botulinum toxin type B currently available to physicians and patients worldwide. View the Veeva Case Study
	Solvay Pharmaceuticals, Inc., Marietta, Georgia, is the U.S. subsidiary of Solvay Pharmaceuticals, Brussels. A research based pharmaceutical company, Solvay seeks to fulfill carefully selected, unmet medical needs in the therapeutic areas of neuroscience, cardio-metabolic, influence vaccines, gastroenterology, and men's and women's health.

© Copyright 2010 Veeva Systems.